D01 - A Dialogue With FDA

Thursday, November 18, 2021

1:30 PM – 2:30 PM ET

Location: Livestreamed

Sponsored By

This session will be an open forum led by a panel of FDA representatives, and who will provide brief updates on FDA activities within their Center/Office. The session will then be open for audience questions. Attendees are encouraged to come with questions of interest to all.

Learning Objectives:

Hear from FDA representatives about new and evolving issues, initiatives, regulations, and guidance
Ask questions about evolving issues and initiatives at the FDA

Speaker(s)

BF

Bridget Foltz, MS, MT(ASCP)

Office of Clinical Policy, Food and Drug Administration
MH

Minerva Hughes, JD, PhD

FDA
Diane M. Maloney, JD

Food and Drug Administration
Silver Spring, MD
Ann Meeker-O'Connell, MS

FDA
Silver Spring , MD
Laurie Muldowney, MD

FDA
Kevin A. Prohaska, DO, MPH

Food and Drug Administration
Silver Spring, MD